These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series. Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A. Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176 [Abstract] [Full Text] [Related]
4. Salvage radiation therapy following radical prostatectomy. A national Danish study. Ervandian M, Høyer M, Petersen SE, Sengeløv L, Hansen S, Holmberg M, Sveistrup J, Meidahl Petersen P, Borre M. Acta Oncol; 2016 May; 55(5):598-603. PubMed ID: 26399602 [Abstract] [Full Text] [Related]
5. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N. Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1493-9. PubMed ID: 22401922 [Abstract] [Full Text] [Related]
6. Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy. Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen Q, McGuire SE, Mahmood U, Frank SJ, Hoffman KE. Prostate Cancer Prostatic Dis; 2017 Dec 01; 20(4):389-394. PubMed ID: 28462945 [Abstract] [Full Text] [Related]
9. A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24. González-San Segundo C, López Campos F, Gómez Iturriaga A, Rodríguez A, Olivera J, Duque-Santana V, Sancho G, Henríquez I, Conde AJ, Valero J, Maldonado X, Glaria L, Caballero B, Sanmamed N, Mases J, Boladeras-Inglada AM, Montijano M, Santos M, Álvarez A, Martínez JI, Couñago F. BJU Int; 2024 Oct 01; 134(4):568-577. PubMed ID: 39041411 [Abstract] [Full Text] [Related]
10. National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer. Yang DD, Muralidhar V, Mahal BA, Labe SA, Nezolosky MD, Vastola ME, King MT, Martin NE, Orio PF, Choueiri TK, Trinh QD, Spratt DE, Hoffman KE, Feng FY, Nguyen PL. Int J Radiat Oncol Biol Phys; 2017 Jun 01; 98(2):338-343. PubMed ID: 28463152 [Abstract] [Full Text] [Related]
11. The Effect of Salvage Radiation Therapy on Survival, Functional Outcomes, and Quality of Life in Men with Persistent Prostate-specific Antigen After Robot-Assisted Radical Prostatectomy: Which Patient Benefits More? Özman O, Berrens AC, Pos F, van Leeuwen PJ, van der Poel H. Pract Radiat Oncol; 2022 Jun 01; 12(6):e538-e546. PubMed ID: 35843543 [Abstract] [Full Text] [Related]
13. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment. Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ. Int J Radiat Oncol Biol Phys; 2012 Sep 01; 84(1):112-8. PubMed ID: 22300563 [Abstract] [Full Text] [Related]
14. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY. Eur Urol; 2016 Jan 01; 69(1):50-7. PubMed ID: 26004800 [Abstract] [Full Text] [Related]
15. Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer. Dess RT, Sun Y, Jackson WC, Jairath NK, Kishan AU, Wallington DG, Mahal BA, Stish BJ, Zumsteg ZS, Den RB, Hall WA, Gharzai LA, Jaworski EM, Reichert ZR, Morgan TM, Mehra R, Schaeffer EM, Sartor O, Nguyen PL, Lee WR, Rosenthal SA, Michalski JM, Schipper MJ, Dignam JJ, Pisansky TM, Zietman AL, Sandler HM, Efstathiou JA, Feng FY, Shipley WU, Spratt DE. JAMA Oncol; 2020 May 01; 6(5):735-743. PubMed ID: 32215583 [Abstract] [Full Text] [Related]
16. Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice. Sanmamed N, Glicksman RM, Herrera-Caceres J, Lehrer EJ, Heaton J, Hansen AR, Chung P, Fleshner NE, Den RB, Zaorsky NG, Berlin A. Urol Oncol; 2020 Nov 01; 38(11):848.e1-848.e7. PubMed ID: 32553790 [Abstract] [Full Text] [Related]
17. Role of androgen deprivation therapy in early salvage radiation among patients with prostate-specific antigen level of 0.5 or less. Parekh A, Chen MH, Graham P, Mahal BA, Hirsch AE, Nakabayashi M, Evan C, Kantoff PW, Martin NE, Nguyen PL. Clin Genitourin Cancer; 2015 Feb 01; 13(1):e1-6. PubMed ID: 25103271 [Abstract] [Full Text] [Related]
18. The Effect of Androgen Deprivation Therapy Before Salvage Whole-gland Cryoablation After Primary Radiation Failure in Prostate Cancer Treatment. Li R, Ruckle HC, Schlaifer AE, El-Shafei A, Yu C, Jones JS. Urology; 2015 May 01; 85(5):1137-1142. PubMed ID: 25799176 [Abstract] [Full Text] [Related]
19. Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit. Gupta M, Patel HD, Schwen ZR, Tran PT, Partin AW. BJU Int; 2019 Feb 01; 123(2):252-260. PubMed ID: 29626845 [Abstract] [Full Text] [Related]
20. Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study. Kim M, Song C, Jeong IG, Choi SK, Park M, Shim M, Kim YS, You D, Hong JH, Kim CS, Ahn H. BMC Cancer; 2018 Mar 09; 18(1):271. PubMed ID: 29523103 [Abstract] [Full Text] [Related] Page: [Next] [New Search]